Although FGF21 has several beneficial effects for glucose and lipid metabolism1,2, circulating FGF21 levels are paradoxically increased in hepatosteatosis, obesity, and type 2 diabetes1–8. This evidence concerns the gene FGF21 and obesity disorder.